CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer

Jackson, 2019, Stereotactic body radiation therapy for localized prostate cancer: a systematic review and meta-analysis of over 6,000 patients treated on prospective studies, Int J Radiat Oncol Biol Phys, 104, 778, 10.1016/j.ijrobp.2019.03.051 Anwar, 2014, Hypofractionated SBRT versus conventionally fractionated EBRT for prostate cancer: comparison of PSA slope and nadir, Radiat Oncol, 9, 1, 10.1186/1748-717X-9-42 Chen, 2013, Stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer: the Georgetown University experience, Radiat Oncol, 8, 1, 10.1186/1748-717X-8-58 Madsen, 2007, Stereotactic hypofractionated accurate radiotherapy of the prostate (SHARP), 33.5 Gy in five fractions for localized disease: first clinical trial results. International Journal of Radiation Oncology* Biology*, Physics, 67, 1099 Katz, 2013, Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years, Radiat Oncol, 8, 1, 10.1186/1748-717X-8-118 Andruska, 2022, Propensity-Weighted Survival Analysis of SBRT vs. Conventional Radiotherapy in Unfavorable Intermediate-Risk Prostate Cancer, Clin Genitourin Cancer, 20, 123, 10.1016/j.clgc.2021.11.012 Dunlap, 2010, Helical tomotherapy-based STAT stereotactic body radiation therapy: Dosimetric evaluation for a real-time SBRT treatment planning and delivery program, Med Dosim, 35, 312, 10.1016/j.meddos.2010.08.002 Collins, 2011, Six-dimensional correction of intra-fractional prostate motion with CyberKnife stereotactic body radiation therapy, Front Oncol, 1, 48 Court, 2005, An automatic CT-guided adaptive radiation therapy technique by online modification of multileaf collimator leaf positions for prostate cancer. International Journal of Radiation Oncology* Biology*, Physics, 62, 154 Byrne, 2022, Varian ethos online adaptive radiotherapy for prostate cancer: Early results of contouring accuracy, treatment plan quality, and treatment time, J Appl Clin Med Phys, 23, e13479, 10.1002/acm2.13479 Tetar, 2019, Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer, Phys Imaging Radiat Oncol, 9, 69, 10.1016/j.phro.2019.02.002 Alongi, 2020, 1.5 T MR-guided and daily adapted SBRT for prostate cancer: feasibility, preliminary clinical tolerability, quality of life and patient-reported outcomes during treatment, Radiat Oncol, 15, 10.1186/s13014-020-01510-w Leeman, 2022, Magnetic Resonance-Guided Prostate Stereotactic Body Radiation Therapy With Daily Online Plan Adaptation: Results of a Prospective Phase 1 Trial and Supplemental Cohort, Adv Radiat Oncol, 7 Murthy, 2021, Prostate-Only Versus Whole-Pelvic Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer (POP-RT): Outcomes From Phase III Randomized Controlled Trial, J Clin Oncol, 39, 1234, 10.1200/JCO.20.03282 Alayed, 2020, Evaluating the Tolerability of a Simultaneous Focal Boost to the Gross Tumor in Prostate SABR: A Toxicity and Quality-of-Life Comparison of Two Prospective Trials, Int J Radiat Oncol Biol Phys, 107, 136, 10.1016/j.ijrobp.2019.12.044